Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Mario Clerici

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

HIV Infections

Living Beings

HIV-1
HIV

Chemicals & Drugs

Anatomy

Phenomena

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Saresella Marina; Marventano Ivana; Guerini Franca Rosa; Mancuso Roberta; Ceresa Lara; Zanzottera Milena; Rusconi Beatrice; Maggioni Emanuela; Tinelli Carmine; Clerici Mario
An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children.
Guerini F R; Beghi E; Riboldazzi G; Zangaglia R; Pianezzola C; Bono G; Casali C; Di Lorenzo C; Agliardi C; Nappi G; Clerici M; Martignoni E
BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease.
Trabattoni Daria; Saresella Marina; Pacei Michela; Marventano Ivana; Mendozzi Laura; Rovaris Marco; Caputo Domenico; Borelli Manuela; Clerici Mario
Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mario Clerici (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Saresella Marina; Marventano Ivana; Guerini Franca Rosa; Mancuso Roberta; Ceresa Lara; Zanzottera Milena; Rusconi Beatrice; Maggioni Emanuela; Tinelli Carmine; Clerici Mario
An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children.
Biological psychiatry 2009;66(10):978-84.
2009: Guerini F R; Beghi E; Riboldazzi G; Zangaglia R; Pianezzola C; Bono G; Casali C; Di Lorenzo C; Agliardi C; Nappi G; Clerici M; Martignoni E
BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16(11):1240-5.
2009: Trabattoni Daria; Saresella Marina; Pacei Michela; Marventano Ivana; Mendozzi Laura; Rovaris Marco; Caputo Domenico; Borelli Manuela; Clerici Mario
Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(8):4984-93.
2009: Clerici Mario; Arosio Beatrice; Mundo Emanuela; Cattaneo Elisabetta; Pozzoli Sara; Dell'osso Bernardo; Vergani Carlo; Trabattoni Daria; Altamura A Carlo
Cytokine polymorphisms in the pathophysiology of mood disorders.
CNS spectrums 2009;14(8):419-25.
2009: Saresella M; Rolland A; Marventano I; Cavarretta R; Caputo D; Marche P; Perron H; Clerici M
Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2009;15(4):443-7.
2009: Lucignani Giovanni; Orunesu Eva; Cesari Miriam; Marzo Katia; Pacei Michela; Bechi Giulia; Gori Andrea; Gaito Sabrina; Clerici Mario; Chiti Arturo
FDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables.
European journal of nuclear medicine and molecular imaging 2009;36(4):640-7.
2009: Guerini Franca R; Bolognesi Elisabetta; Manca Salvatorica; Sotgiu Stefano; Zanzottera Milena; Agliardi Cristina; Usai Sonia; Clerici Mario
Family-based transmission analysis of HLA genetic markers in Sardinian children with autistic spectrum disorders.
Human immunology 2009;70(3):184-90.
2009: Tincati Camilla; Biasin Mara; Bandera Alessandra; Violin Michela; Marchetti Giulia; Piacentini Luca; Vago Gian Luca; Balotta Claudia; Moroni Mauro; Franzetti Fabio; Clerici Mario; Gori Andrea
Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
Antiviral therapy 2009;14(3):321-30.
2008: Mancuso Roberta; Biffi Renato; Valli Marilena; Bellinvia Monica; Tourlaki Athanasia; Ferrucci Silvia; Brambilla Lucia; Delbue Serena; Ferrante Pasquale; Tinelli Carmine; Clerici Mario
HHV8 a subtype is associated with rapidly evolving classic Kaposi's sarcoma.
Journal of medical virology 2008;80(12):2153-60.
2008: Saresella Marina; Marventano Ivana; Guerini Franca Rosa; Zanzottera Milena; Delbue Serena; Marchioni Enrico; Maserati Renato; Longhi Renato; Ferrante Pasquale; Clerici Mario
Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseases.
Clinical immunology (Orlando, Fla.) 2008;129(3):509-17.
2008: Boasso Adriano; Hardy Andrew W; Landay Alan L; Martinson Jeffrey L; Anderson Stephanie A; Dolan Matthew J; Clerici Mario; Shearer Gene M
PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes.
Clinical immunology (Orlando, Fla.) 2008;129(1):132-44.
2008: Saresella Marina; Marventano Ivana; Longhi Renato; Lissoni Francesca; Trabattoni Daria; Mendozzi Laura; Caputo Domenico; Clerici Mario
CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(10):3500-8.
2008: Viganò Alessandra; Zuccotti Gian Vincenzo; Pacei Michela; Erba Paola; Castelletti Eleonora; Giacomet Vania; Amendola Antonella; Pariani Elena; Tanzi Elisabetta; Clerici Mario
Humoral and cellular response to influenza vaccine in HIV-infected children with full viroimmunologic response to antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2008;48(3):289-96.
2008: Gori Andrea; Tincati Camilla; Rizzardini Giuliano; Torti Carlo; Quirino Tiziana; Haarman Monique; Ben Amor Kaouther; van Schaik Jacqueline; Vriesema Aldwin; Knol Jan; Marchetti Giulia; Welling Gjalt; Clerici Mario
Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis.
Journal of clinical microbiology 2008;46(2):757-8.
2008: Croce F; Piconi S; Atzeni F; Sarzi-Puttini P; Galli M; Clerici M
HIV/AIDS: epidemic update, new treatment strategies and impact on autoimmunity.
Clinical and experimental rheumatology 2008;26(1 Suppl 48):S48-52.
2008: Bandera Alessandra; Trabattoni Daria; Pacei Michela; Fasano Francesca; Suardi Elisa; Cesari Miriam; Marchetti Giulia; Pogliani Enrico M; Franzetti Fabio; Clerici Mario; Gori Andrea
Fully immunocompetent CD8+ T lymphocytes are present in autologous haematopoietic stem cell transplantation recipients despite an ineffectual T-helper response.
PloS one 2008;3(10):e3616.
2008: Della Bella Silvia; Taddeo Adriano; Calabrò Maria L; Brambilla Lucia; Bellinvia Monica; Bergamo Elisa; Clerici Mario; Villa Maria L
Peripheral blood endothelial progenitors as potential reservoirs of Kaposi's sarcoma-associated herpesvirus.
PloS one 2008;3(1):e1520.
2007: Biasin Mara; Piacentini Luca; Lo Caputo Sergio; Kanari Yasuyoshi; Magri Giuliana; Trabattoni Daria; Naddeo Valentina; Lopalco Lucia; Clivio Alberto; Cesana Eugenio; Fasano Francesca; Bergamaschi Cristina; Mazzotta Francesco; Miyazawa Masaaki; Clerici Mario
Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals.
The Journal of infectious diseases 2007;195(7):960-4.
2007: Zuccotti Gian Vincenzo; Vigano Alessandra; Borelli Manuela; Saresella Marina; Giacomet Vania; Clerici Mario
Modulation of innate and adaptive immunity by lactoferrin in human immunodeficiency virus (HIV)-infected, antiretroviral therapy-naïve children.
International journal of antimicrobial agents 2007;29(3):353-5.
2007: Piconi Stefania; Trabattoni Daria; Saresella Marina; Iemoli Enrico; Schenal Monica; Fusi Alessandra; Borelli Manuela; Chen Lieping; Mascheri Ambra; Clerici Mario
Effects of specific immunotherapy on the B7 family of costimulatory molecules in allergic inflammation.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(3):1931-7.
2007: Vigano Alessandra; Saresella Marina; Schenal Monica; Erba Paola; Piacentini Luca; Tornaghi Raffaella; Naddeo Valentina; Giacomet Vania; Borelli Manuela; Trabattoni Daria; Clerici Mario
Immune activation and normal levels of endogenous antivirals are seen in healthy adolescents born of HIV-infected mothers.
AIDS (London, England) 2007;21(2):245-8.
2007: Missé Dorothée; Yssel Hans; Trabattoni Daria; Oblet Christelle; Lo Caputo Sergio; Mazzotta Francesco; Pène Jérome; Gonzalez Jean-Paul; Clerici Mario; Veas Francisco
IL-22 participates in an innate anti-HIV-1 host-resistance network through acute-phase protein induction.
Journal of immunology (Baltimore, Md. : 1950) 2007;178(1):407-15.
2007: Segat L; Pontillo A; Annoni G; Trabattoni D; Vergani C; Clerici M; Arosio B; Crovella S
PIN1 promoter polymorphisms are associated with Alzheimer's disease.
Neurobiology of aging 2007;28(1):69-74.
2007: Castelletti Eleonora; Lo Caputo Sergio; Kuhn Louise; Borelli Manuela; Gajardo Johanna; Sinkala Moses; Trabattoni Daria; Kankasa Chipepo; Lauri Eleonora; Clivio Alberto; Piacentini Luca; Bray Dorothy H; Aldrovandi Grace M; Thea Donald M; Veas Francisco; Nebuloni Manuela; Mazzotta Francesco; Clerici Mario
The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection.
PloS one 2007;2(10):e969.
2006: Kuhn Louise; Trabattoni Daria; Kankasa Chipepo; Sinkala Moses; Lissoni Francesca; Ghosh Mrinal; Aldrovandi Grace; Thea Don; Clerici Mario
Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants.
The Journal of pediatrics 2006;149(5):611-6.
2006: Rizzardini Giuliano; Trabattoni Daria; Capetti Amedeo; Castelletti Eleonora; Migliorino Marco; Panebianco Ruggero; Pacei Michela; Quirino Tiziana; Clerici Mario
An immunological comparison of third companion in advanced drug-naive HIV-infected patients.
HIV clinical trials 2006;7(5):221-8.
2006: Kuhn Louise; Coutsoudis Anna; Trabattoni Daria; Archary Derseree; Rossi Tatiana; Segat Ludovica; Clerici Mario; Crovella Sergio
Synergy between mannose-binding lectin gene polymorphisms and supplementation with vitamin A influences susceptibility to HIV infection in infants born to HIV-positive mothers.
The American journal of clinical nutrition 2006;84(3):610-5.
2006: Lucignani Giovanni; Ottobrini Luisa; Martelli Cristina; Rescigno Maria; Clerici Mario
Molecular imaging of cell-mediated cancer immunotherapy.
Trends in biotechnology 2006;24(9):410-8.
2006: Trabattoni Daria; Schenal Monica; Cesari Miriam; Castelletti Eleonora; Pacei Michela; Goldberg Billi; Gori Andrea; Clerici Mario
Low interleukin-10 production is associated with diabetes in HIV-infected patients undergoing antiviral therapy.
Medical microbiology and immunology 2006;195(3):125-32.
2006: Marchetti Giulia; Gori Andrea; Casabianca Anna; Magnani Mauro; Franzetti Fabio; Clerici Mario; Perno Carlo-Federico; Monforte Antonella d'Arminio; Galli Massimo; Meroni Luca
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
AIDS (London, England) 2006;20(13):1727-36.
2006: Capetti Amedeo; Piconi Stefania; Magni Carlo; Quirino Tiziana; Trabattoni Daria; Clerici Mario
Unusual presentation of acute cytomegalovirus disease during primary HIV-1 infection: antigen-specific T-cell response analyses and clinical outcome.
AIDS (London, England) 2006;20(11):1566-7.
2006: Bandera Alessandra; Gazzola Lidia; Franzetti Fabio; Tosca Nicoletta; Sacchi Elisabetta; Clerici Mario; Gori Andrea
Unusual T-cell repopulation after autologous stem cell transplantation for HIV-associated lymphoma.
Transplantation 2006;81(12):1752-3.
2006: Viganò Alessandra; Trabattoni Daria; Schneider Laura; Ottaviani Francesco; Aliffi Antonia; Longhi Erika; Rusconi Stefano; Clerici Mario
Failure to eradicate HIV despite fully successful HAART initiated in the first days of life.
The Journal of pediatrics 2006;148(3):389-91.
2006: Milazzo Laura; Biasin Mara; Gatti Nadia; Piacentini Luca; Niero Fosca; Zanone Poma Barbara; Galli Massimo; Moroni Mauro; Clerici Mario; Riva Agostino
Thalidomide in the treatment of chronic hepatitis C unresponsive to alfa-interferon and ribavirin.
The American journal of gastroenterology 2006;101(2):399-402.
2006: Trabattoni Daria; Clivio Alberto; Bray Dorothy H; Bhagat Lakshmi; Beltrami Silvia; Maffeis Giada; Cesana Eugenio; Lowry Peter; Lissoni Francesca; Kandimalla Ekambar R; Sullivan Timothy; Agrawal Sudhir; Bartholomew Richard; Clerici Mario
Immunization with gp120-depleted whole killed HIV immunogen and a second-generation CpG DNA elicits strong HIV-specific responses in mice.
Vaccine 2006;24(9):1470-7.
2005: Ottobrini L; Lucignani G; Clerici M; Rescigno M
Assessing cell trafficking by noninvasive imaging techniques: applications in experimental tumor immunology.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2005;49(4):361-6.
2005: Saresella Marina; Marventano Ivana; Speciale Livianna; Ruzzante Stefania; Trabattoni Daria; Della Bella Silvia; Filippi Massimo; Fasano Francesca; Cavarretta Rosella; Caputo Domenico; Clerici Mario; Ferrante Pasquale
Programmed cell death of myelin basic protein-specific T lymphocytes is reduced in patients with acute multiple sclerosis.
Journal of neuroimmunology 2005;166(1-2):173-9.
2005: Kanari Yasuyoshi; Clerici Mario; Abe Hiroyuki; Kawabata Hiroyuki; Trabattoni Daria; Caputo Sergio Lo; Mazzotta Francesco; Fujisawa Hironori; Niwa Atsuko; Ishihara Chiaki; Takei Yumiko A; Miyazawa Masaaki
Genotypes at chromosome 22q12-13 are associated with HIV-1-exposed but uninfected status in Italians.
AIDS (London, England) 2005;19(10):1015-24.
2005: Kuhn Louise; Trabattoni Daria; Kankasa Chipepo; Semrau Katherine; Kasonde Prisca; Lissoni Francesca; Sinkala Moses; Ghosh Mrinal; Vwalika Cheswa; Aldrovandi Grace M; Thea Donald M; Clerici Mario
Alpha-defensins in the prevention of HIV transmission among breastfed infants.
Journal of acquired immune deficiency syndromes (1999) 2005;39(2):138-42.
2005: Schenal Monica; Lo Caputo Sergio; Fasano Francesca; Vichi Francesca; Saresella Marina; Pierotti Piera; Villa Maria Luisa; Mazzotta Francesco; Trabattoni Daria; Clerici Mario
Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients.
AIDS (London, England) 2005;19(7):653-61.
2005: Magri Giuliana; Clerici Mario; Dall'Ara Paola; Biasin Mara; Caramelli Maria; Casalone Cristina; Giannino Maria Laura; Longhi Renato; Piacentini Luca; Della Bella Silvia; Gazzuola Paola; Martino Piera Anna; Della Bella Silvia; Pollera Claudia; Puricelli Maria; Servida Francesco; Crescio Ines; Boasso Adriano; Ponti Wilma; Poli Giorgio
Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters.
Vaccine 2005;23(22):2862-8.
2005: Lopalco L; Barassi C; Paolucci C; Breda D; Brunelli D; Nguyen M; Nouhin J; Luong T T; Truong L X; Clerici M; Calori G; Lazzarin A; Pancino G; Burastero S E
Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin.
The Journal of general virology 2005;86(Pt 2):339-48.
2004: Vigano Alessandra; Saresella Marina; Trabattoni Daria; Giacomet Vania; di Natale Berardo; Merlo Marzia; Venuto Annunziata; Villa Maria Luisa; Vanzulli Stefano; Ferrante Pasquale; Clerici Mario
Growth hormone in T-lymphocyte thymic and postthymic development: a study in HIV-infected children.
The Journal of pediatrics 2004;145(4):542-8.
2004: Arosio Beatrice; Trabattoni Daria; Galimberti Lorenza; Bucciarelli Paolo; Fasano Francesca; Calabresi Carmen; Cazzullo Carlo Lorenzo; Vergani Carlo; Annoni Giorgio; Clerici Mario
Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
Neurobiology of aging 2004;25(8):1009-15.
2004: Gori Andrea; Trabattoni Daria; Bandera Alessandra; Saresella Marina; Marchetti Giulia; Gazzola Lidia; Biasin Mara; Rhodes John; McDade Hugh; Panebianco Ruggero; Galli Massimo; Moroni Mauro; Ferrante Pasquale; Thomas Nicola; Franzetti Fabio; Bray Dorothy; Clerici Mario
Immunomodulation induced by tucaresol in HIV infection: results of a 16 week pilot Phase I/II trial.
Antiviral therapy 2004;9(4):603-14.
2004: Marchetti Giulia; Meroni Luca; Molteni Chiara; Taskaris Greta; Gazzola Lidia; Galli Massimo; Clerici Mario; Moroni Mauro; Franzetti Fabio; Gori Andrea
IL-7/IL-7 receptor system regulation following IL-2 immunotherapy in HIV-infected patients.
Antiviral therapy 2004;9(3):447-52.
2004: Trabattoni Daria; Piconi Stefania; Biasin Mara; Rizzardini Giuliano; Migliorino Marco; Seminari Elena; Boasso Adriano; Piacentini Luca; Villa Maria Luisa; Maserati Renato; Clerici Mario
Granule-dependent mechanisms of lysis are defective in CD8 T cells of HIV-infected, antiretroviral therapy-treated individuals.
AIDS (London, England) 2004;18(6):859-69.
2004: Trabattoni Daria; Caputo Sergio Lo; Maffeis Giada; Vichi Francesca; Biasin Mara; Pierotti Piera; Fasano Francesca; Saresella Marina; Franchini Mario; Ferrante Pasquale; Mazzotta Francesco; Clerici Mario
Human alpha defensin in HIV-exposed but uninfected individuals.
Journal of acquired immune deficiency syndromes (1999) 2004;35(5):455-63.
2004: Marchetti Giulia; Meroni Luca; Molteni Chiara; Bandera Alessandra; Franzetti Fabio; Galli Massimo; Moroni Mauro; Clerici Mario; Gori Andrea
Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics.
AIDS (London, England) 2004;18(2):211-6.
2004: Della Bella Silvia; Nicola Stefania; Riva Antonio; Biasin Mara; Clerici Mario; Villa Maria Luisa
Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha.
Journal of leukocyte biology 2004;75(1):106-16.
2003: Agarossi Alberto; Casolati Elena; Valieri Monica; Ferrazzi Enrico; Maffeis Giada; Trabattoni Daria; Clerici Mario
Mucosal immune response to Human Papilloma Virus (HPV) infection in HIV positive women.
Medycyna wieku rozwojowego 2003;7(4 Pt 1):495-502.
2003: Cazzullo Carlo Lorenzo; Trabattoni Daria; Saresella Marina; Annoni Giorgio; Arosio Beatrice; Clerici Mario
Research on psychoimmunology.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2003;4(3):119-23.
2003: Ingegnoli Francesca; Trabattoni Daria; Saresella Marina; Fantini Flavio; Clerici Mario
Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis.
Clinical immunology (Orlando, Fla.) 2003;108(1):21-8.
2003: Biasin Mara; Boasso Adriano; Piacentini Luca; Trabattoni Daria; Magri Giuliana; Deshmuks Ranjana; Deshpande Alaka; Clerici Mario
IL-4 and CXCR4 upregulation in HIV-infected and uninfected individuals from Maharashtra-Mumbai.
AIDS (London, England) 2003;17(10):1563-5.
2003: Galli Massimo; Gervasoni Cristina; Ridolfo Anna Lisa; Trabattoni Daria; Santambrogio Sara; Vaccarezza Mauro; Meroni Luca; Trifirò Giuliana; Moroni Mauro; Norbiato Guido; Clerici Mario
Cytokine production in women with antiretroviral treatment-associated breast fat accumulation and limb wasting.
AIDS (London, England) 2003;17 Suppl 1():S155-61.
2003: Trabattoni Daria; Saresella Marina; Biasin Mara; Boasso Adriano; Piacentini Luca; Ferrante Pasquale; Dong Haidong; Maserati Renato; Shearer Gene M; Chen Lieping; Clerici Mario
B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression.
Blood 2003;101(7):2514-20.
2003: Lo Caputo Sergio; Trabattoni Daria; Vichi Francesca; Piconi Stefania; Lopalco Lucia; Villa Maria Luisa; Mazzotta Francesco; Clerici Mario
Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men.
AIDS (London, England) 2003;17(4):531-9.
2002: Taliani Gloria; Badolato Maria Concetta; Nigro Giovanni; Biasin Mara; Boddi Vieri; Pasquazzi Caterina; Clerici Mario
Serum concentration of gammaGT is a surrogate marker of hepatic TNF-alpha mRNA expression in chronic hepatitis C.
Clinical immunology (Orlando, Fla.) 2002;105(3):279-85.
2002: Clerici Mario; Boasso Adriano; Rizzardini Giuliano; Deshpande Alaka; Biasin Mara
AIDS in Africa.
Lancet 2002;360(9343):1424.
2002: Clerici Mario; Saresella Marina; Trabattoni Daria; Ferrante Pasquale; Vanzulli Angelo; Vigano Alessandra
Thymic volume predicts long-term immune reconstitution in HIV-infected children treated with highly active antiretroviral therapy.
AIDS (London, England) 2002;16(16):2219-21.
2002: Clerici Mario; Seminari Elena; Maggiolo Franco; Pan Angelo; Migliorino Marco; Trabattoni Daria; Castelli Francesco; Suter Fredy; Fusi Maria Luisa; Minoli Lorenzo; Carosi Giampiero; Maserati Renato;
Early and late effects of highly active antiretroviral therapy: a 2 year follow-up of antiviral-treated and antiviral-naive chronically HIV-infected patients.
AIDS (London, England) 2002;16(13):1767-73.
2002: Clerici Mario; Barassi Claudia; Devito Claudia; Pastori Claudia; Piconi Stefania; Trabattoni Daria; Longhi Renato; Hinkula Jorma; Broliden Kristina; Lopalco Lucia
Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41.
AIDS (London, England) 2002;16(13):1731-41.
2002: Trabattoni Daria; Lo Caputo Sergio; Biasin Mara; Seminari Elena; Di Pietro Massimo; Ravasi Giovanni; Mazzotta Francesco; Maserati Renato; Clerici Mario
Modulation of human immunodeficiency virus (HIV)-specific immune response by using efavirenz, nelfinavir, and stavudine in a rescue therapy regimen for HIV-infected, drug-experienced patients.
Clinical and diagnostic laboratory immunology 2002;9(5):1114-8.
2002: Marchetti Giulia; Meroni Luca; Varchetta Stefania; Terzieva Velislava; Bandera Alessandra; Manganaro Daniele; Molteni Chiara; Trabattoni Daria; Fossati Sabrina; Clerici Mario; Galli Massimo; Moroni Mauro; Franzetti Fabio; Gori Andrea
Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment.
The Journal of infectious diseases 2002;186(5):606-16.
2002: Devito Claudia; Hinkula Jorma; Kaul Rupert; Kimani Joshua; Kiama Peter; Lopalco Lucia; Barass Claudia; Piconi Stefania; Trabattoni Daria; Bwayo Job J; Plummer Francis; Clerici Mario; Broliden Kristina
Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.
Journal of acquired immune deficiency syndromes (1999) 2002;30(4):413-20.
2002: Esposito Susanna; Faldella Giacomo; Giammanco Anna; Bosis Samantha; Friscia Ornella; Clerici Mario; Principi Nicola
Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants.
Vaccine 2002;20(23-24):2928-32.
2002: Piconi Stefania; Trabattoni Daria; Iemoli Enrico; Fusi Maria Luisa; Villa Maria Luisa; Milazzo Francesco; Clerici Mario
Immune profiles of patients with chronic idiopathic urticaria.
International archives of allergy and immunology 2002;128(1):59-66.
2002: Trabattoni D; Fossati S; Biasin M; Boasso A; Rizzardini G; Maseratti R; Clerici M
Functional analysis of HIV-specific cytotoxic T lymphocytes in antiviral-treated- and-naive patients: a preliminary report.
Journal of biological regulators and homeostatic agents 2002;16(1):25-9.
2002: Cazzullo Carlo L; Sacchetti Emilio; Galluzzo Alessandro; Panariello Adelaide; Adorni Andrea; Pegoraro Marco; Bosis Simona; Colombo Fulvia; Trabattoni Daria; Zagliani Arianna; Clerici Mario
Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(1):33-9.
2002: Lucini Daniela; Norbiato Guido; Clerici Mario; Pagani Massimo
Hemodynamic and autonomic adjustments to real life stress conditions in humans.
Hypertension 2002;39(1):184-8.
2001: Lukwiya M; Rizzardini G; Trabattoni D; Piconi S; Saresella M; Declich S; Fossati S; Clerici M
Evaluation of immune activation in HIV-infected and uninfected African individuals by single-cell analysis of cytokine production.
Journal of acquired immune deficiency syndromes (1999) 2001;28(5):429-36.
2001: Clerici M; Saresella M; Trabattoni D; Speciale L; Fossati S; Ruzzante S; Cavaretta R; Filippi M; Caputo D; Ferrante P
Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease.
Journal of neuroimmunology 2001;121(1-2):88-101.
2001: Broliden K; Hinkula J; Devito C; Kiama P; Kimani J; Trabbatoni D; Bwayo J J; Clerici M; Plummer F; Kaul R
Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers.
Immunology letters 2001;79(1-2):29-36.
2001: Clerici M; Declich S; Rizzardini G
African enigma: key player in human immunodeficiency virus pathogenesis in developing countries?
Clinical and diagnostic laboratory immunology 2001;8(5):864-6.
2001: Kuhn L; Coutsoudis A; Moodley D; Mngqundaniso N; Trabattoni D; Shearer G M; Clerici M; Coovadia H M
Interferon-gamma and interleukin-10 production among HIV-1-infected and uninfected infants of HIV-1-infected mothers.
Pediatric research 2001;50(3):412-6.
2001: Esposito S; Agliardi T; Giammanco A; Faldella G; Cascio A; Bosis S; Friscia O; Clerici M; Principi N
Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.
Infection and immunity 2001;69(7):4516-20.
2001: Kuhn L; Meddows-Taylor S; Gray G; Trabattoni D; Clerici M; Shearer G M; Tiemessen C
Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission.
Clinical and experimental immunology 2001;123(3):443-50.
2001: Cazzullo C L; Sacchetti E; Galluzzo A; Panariello A; Colombo F; Zagliani A; Clerici M
Cytokine profiles in drug-naive schizophrenic patients.
Schizophrenia research 2001;47(2-3):293-8.
2001: Kuhn L; Coutsoudis A; Moodley D; Trabattoni D; Mngqundaniso N; Shearer G M; Clerici M; Coovadia H M; Stein Z
T-helper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission.
AIDS (London, England) 2001;15(1):1-9.
2000: Clerici M; Cogliati M; Rizzardini G; Colombo F; Fossati S; Rhodes J; Bray D; Piconi S
In vitro immunomodulatory properties of tucaresol in HIV infection.
Clinical immunology (Orlando, Fla.) 2000;97(3):211-20.
2000: Clerici M; Saresella M; Colombo F; Fossati S; Sala N; Bricalli D; Villa M L; Ferrante P; Dally L; Vigano' A
T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV.
Blood 2000;96(12):3866-71.
2000: Devito C; Broliden K; Kaul R; Svensson L; Johansen K; Kiama P; Kimani J; Lopalco L; Piconi S; Bwayo J J; Plummer F; Clerici M; Hinkula J
Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(9):5170-6.
2000: Biasin M; Caputo S L; Speciale L; Colombo F; Racioppi L; Zagliani A; Blé C; Vichi F; Cianferoni L; Masci A M; Villa M L; Ferrante P; Mazzotta F; Clerici M
Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women.
The Journal of infectious diseases 2000;182(5):1365-74.
2000: Clerici M; Butto S; Lukwiya M; Saresella M; Declich S; Trabattoni D; Pastori C; Piconi S; Fracasso C; Fabiani M; Ferrante P; Rizzardini G; Lopalco L
Immune activation in africa is environmentally-driven and is associated with upregulation of CCR5. Italian-Ugandan AIDS Project.
AIDS (London, England) 2000;14(14):2083-92.
2000: Devito C; Hinkula J; Kaul R; Lopalco L; Bwayo J J; Plummer F; Clerici M; Broliden K
Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate.
AIDS (London, England) 2000;14(13):1917-20.
2000: Gori A; Rossi M C; Marchetti G; Trabattoni D; Molteni C; Cogliati M; Bandera A; Clerici M; Franzetti F
Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease.
AIDS (London, England) 2000;14(12):1859-61.
2000: Gori A; Rossi M C; Trabattoni D; Marchetti G; Fusi M L; Molteni C; Clerici M; Franzetti1 F
Tumor necrosis factor-alpha increased production during thalidomide treatment in patients with tuberculosis and human immunodeficiency virus coinfection.
The Journal of infectious diseases 2000;182(2):639-40.
2000: Piconi S; Trabattoni D; Fusi M L; Milazzo F; Dix L P; Rizzardini G; Colombo F; Bray D; Clerici M
Effect of two different combinations of antiretrovirals (AZT+ddI and AZT+3TC) on cytokine production and apoptosis in asymptomatic HIV infection.
Antiviral research 2000;46(3):171-9.
2000: Trabattoni D; Ferrante P; Fusi M L; Saresella M; Caputo D; Urnovitz H; Cazzullo C L; Clerici M
Augmented type 1 cytokines and human endogenous retroviruses specific immune responses in patients with acute multiple sclerosis.
Journal of neurovirology 2000;6 Suppl 2():S38-41.
2000: Ridolfo A L; Gervasoni C; Antinori S; Pizzuto M; Santambrogio S; Trabattoni D; Clerici M; Galli M
Post-kala-azar dermal leishmaniasis during highly active antiretroviral therapy in an AIDS patient infected with Leishmania infantum.
The Journal of infection 2000;40(2):199-202.
2000: Lopalco L; Barassi C; Pastori C; Longhi R; Burastero S E; Tambussi G; Mazzotta F; Lazzarin A; Clerici M; Siccardi A G
CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(6):3426-33.
2000: Di Fabio S; Trabattoni D; Geraci A; Ruzzante S; Panzini G; Fusi M L; Chiarotti F; Corrias F; Belli R; Verani P; Dalgleish A; Clerici M; Titti F
Study of immunological and virological parameters during thalidomide treatment of SIV-infected cynomolgus monkeys.
Journal of medical primatology 2000;29(1):1-10.
2000: Vigano A; Vella S; Saresella M; Vanzulli A; Bricalli D; Di Fabio S; Ferrante P; Andreotti M; Pirillo M; Dally L G; Clerici M; Principi N
Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume.
AIDS (London, England) 2000;14(3):251-61.
2000: Pastori C; Barassi C; Piconi S; Longhi R; Villa M L; Siccardi A G; Clerici M; Lopalco L
HIV neutralizing IgA in exposed seronegative subjects recognise an epitope within the gp41 coiled-coil pocket.
Journal of biological regulators and homeostatic agents 2000;14(1):15-21.
2000: Clerici M; Seminari E; Suter F; Castelli F; Pan A; Biasin M; Colombo F; Trabattoni D; Maggiolo F; Carosi G; Maserati R
Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia. The Master Group.
AIDS (London, England) 2000;14(2):109-16.
2000: Zehender G; Zagliani A; De Maddalena C; Bianchi Bosisio A; Colasante C; Biasin M; Girotto M; Clerici M; Galli M
Peripheral blood lymphocyte proliferation specific for HTLV-Tax peptides in enzyme-linked immunosorbent assay-negative HTLV DNA-positive blood donors.
Journal of acquired immune deficiency syndromes (1999) 2000;23(1):103-5.
2000: Clerici M; Galli M; Bosis S; Gervasoni C; Moroni M; Norbiato G
Immunoendocrinologic abnormalities in human immunodeficiency virus infection.
Annals of the New York Academy of Sciences 2000;917():956-61.
2000: Norbiato G; Trifirò G; Galli M; Gervasoni C; Clerici M
Fat redistribution in HIV-infected patients. A new hormonal-immune disorder?
Annals of the New York Academy of Sciences 2000;917():951-5.
2000: Vigano A; Saresella M; Villa M L; Ferrante P; Clerici M
CD38+CD8+ T cells as a marker of poor response to therapy in HIV-infected individuals.
Chemical immunology 2000;75():207-17.
1999: Viganò A; Dally L; Bricalli D; Sala N; Pirillo M; Saresella M; Trabattoni D; Vella S; Clerici M; Principi N
Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection.
The Journal of pediatrics 1999;135(6):675-82.
1999: Clerici M; Fusi M L; Caputo D; Guerini F R; Trabattoni D; Salvaggio A; Cazzullo C L; Arienti D; Villa M L; Urnovitz H B; Ferrante P
Immune responses to antigens of human endogenous retroviruses in patients with acute or stable multiple sclerosis.
Journal of neuroimmunology 1999;99(2):173-82.
1999: Meroni L; Fusi M L; Varchetta S; Biasin M; Rusconi S; Villa M L; De Vries J E; Aversa G; Galli M; Clerici M
Altered signaling lymphocytic activation molecule (SLAM) expression in HIV infection and redirection of HIV-specific responses via SLAM triggering.
Clinical immunology (Orlando, Fla.) 1999;92(3):276-84.
1999: Mazzoli S; Lopalco L; Salvi A; Trabattoni D; Lo Caputo S; Semplici F; Biasin M; Bl C; Cosma A; Pastori C; Meacci F; Mazzotta F; Villa M L; Siccardi A G; Clerici M
Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons.
The Journal of infectious diseases 1999;180(3):871-5.
1999: Rusconi S; La Seta-Catamancio S; Kurtagic S; Galazzi M; Arienti D; Trabattoni D; Wilken J; Thompson D A; Offord R E; Galli M; Clerici M
Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation.
AIDS research and human retroviruses 1999;15(10):861-7.
1999: Vigano' A; Vella S; Principi N; Bricalli D; Sala N; Salvaggio A; Saresella M; Vanzulli A; Clerici M
Thymus volume correlates with the progression of vertical HIV infection.
AIDS (London, England) 1999;13(5):F29-34.
1999: Milazzo F; Piconi S; Trabattoni D; Magni C; Coen M; Capetti A; Fusi M L; Parravicini C; Clerici M
Intractable pruritus in HIV infection: immunologic characterization.
Allergy 1999;54(3):266-72.
1999: Clerici M; Salvi A; Trabattoni D; Lo Caputo S; Semplici F; Biasin M; Ble C; Meacci F; Romeo C; Piconi S; Mazzotta F; Villa M L; Mazzoli S
A role for mucosal immunity in resistance to HIV infection.
Immunology letters 1999;66(1-3):21-5.
1999: Gervasoni C; Ridolfo A L; Trifirò G; Santambrogio S; Norbiato G; Musicco M; Clerici M; Galli M; Moroni M
Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy.
AIDS (London, England) 1999;13(4):465-71.
1999: Clerici M; Piconi S; Trabattoni D
Vaccine strategies for infectious diseases.
Expert opinion on investigational drugs 1999;8(2):95-106.
1999: Kaul R; Trabattoni D; Bwayo J J; Arienti D; Zagliani A; Mwangi F M; Kariuki C; Ngugi E N; MacDonald K S; Ball T B; Clerici M; Plummer F A
HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers.
AIDS (London, England) 1999;13(1):23-9.
1999: Vigano A; Esposito S; Arienti D; Zagliani A; Massironi E; Principi N; Clerici M
Differential development of type 1 and type 2 cytokines and beta-chemokines in the ontogeny of healthy newborns.
Biology of the neonate 1999;75(1):1-8.
1998: Galli M; Balotta C; Meroni L; Colombo M C; Papagno L; Bagnarelli P; Testa L; Varchetta S; Colombo L; Moroni M; d'Arminio Monforte A; Clerici M; Clementi M
Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy.
AIDS (London, England) 1998;12(18):2500-2.
1998: Rizzardini G; Trabattoni D; Saresella M; Piconi S; Lukwiya M; Declich S; Fabiani M; Ferrante P; Clerici M
Immune activation in HIV-infected African individuals. Italian-Ugandan AIDS cooperation program.
AIDS (London, England) 1998;12(18):2387-96.
1998: Viganó A; Saresella M; Rusconi S; Ferrante P; Clerici M
Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children. Highly active antiretroviral therapy.
Lancet 1998;352(9144):1905-6.
1998: Esposito S; Zehender G; Zuccotti G V; Vegni C; Galli L; Vecchi V; Agostoni C; Rancilio L; De Maddalena C; Clerici M; Principi N
Role of CCR5 chemokine receptor gene in vertical human immunodeficiency virus type 1 transmission and disease progression.
The Pediatric infectious disease journal 1998;17(9):847-9.
1998: Medrano F J; Leal M; Arienti D; Rey C; Zagliani A; Torres Y; Sanchez-Quijano A; Lissen E; Clerici M
Tumor necrosis factor beta and soluble APO-1/Fas independently predict progression to AIDS in HIV-seropositive patients.
AIDS research and human retroviruses 1998;14(10):835-43.
1998: Viganò A; Bricalli D; Trabattoni D; Salvaggio A; Ruzzante S; Barbi M; Di Sanzo G; Principi N; Clerici M
Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of tumor necrosis factor alpha.
AIDS research and human retroviruses 1998;14(9):727-34.
1998: Cazzullo C L; Saresella M; Roda K; Calvo M G; Bertrando P; Doria S; Clerici M; Salvaggio A; Ferrante P
Increased levels of CD8+ and CD4+ 45RA+ lymphocytes in schizophrenic patients.
Schizophrenia research 1998;31(1):49-55.
1998: Norbiato G; Bevilacqua M; Vago T; Clerici M
Glucocorticoid resistance and the immune function in the immunodeficiency syndrome.
Annals of the New York Academy of Sciences 1998;840():835-47.
1998: Ferrante P; Fusi M L; Saresella M; Caputo D; Biasin M; Trabattoni D; Salvaggio A; Clerici E; de Vries J E; Aversa G; Cazzullo C L; Clerici M
Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(3):1514-21.
1998: Di Fabio S; Trabattoni D; Geraci A; Ruzzante S; Panzini G; Fusi M L; Chiarotti F; Corrias F; Belli R; Verani P; Dalgleish A; Clerici M; Titti F
Effects of thalidomide therapy in symptomatic simian immunodeficiency virus-infected cynomolgus monkeys.
AIDS (London, England) 1998;12(3):334-5.
1998: Clerici M; Shearer G M; Clerici E
Cytokine dysregulation in invasive cervical carcinoma and other human neoplasias: time to consider the TH1/TH2 paradigm.
Journal of the National Cancer Institute 1998;90(4):261-3.
1998: Gori A; Franzetti F; Marchetti G; Rossi C; Fusi M L; Ruzzante S; Clerici M
Clinical and immunological improvement in a patient who received thalidomide treatment for refractory Mycobacterium avium complex infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(1):184-5.
1998: Clerici M; Bertrando P; Beltz J; Fornara A; Iraci A; Steiner V; Cazzullo C L
Family adaptation to institutionalised mentally retarded patients. A preliminary report on an Italian population.
The International journal of social psychiatry 1998;44(2):135-46.
1997: Mazzoli S; Trabattoni D; Lo Caputo S; Piconi S; Blé C; Meacci F; Ruzzante S; Salvi A; Semplici F; Longhi R; Fusi M L; Tofani N; Biasin M; Villa M L; Mazzotta F; Clerici M
HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals.
Nature medicine 1997;3(11):1250-7.
1997: Balotta C; Bagnarelli P; Violin M; Ridolfo A L; Zhou D; Berlusconi A; Corvasce S; Corbellino M; Clementi M; Clerici M; Moroni M; Galli M
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient.
AIDS (London, England) 1997;11(10):F67-71.
1997: Clerici M; Fusi M L; Ruzzante S; Piconi S; Biasin M; Arienti D; Trabattoni D; Villa M L
Type 1 and type 2 cytokines in HIV infection -- a possible role in apoptosis and disease progression.
Annals of medicine 1997;29(3):185-8.
1997: Norbiato G; Bevilacqua M; Vago T; Clerici M
Glucocorticoids and Th-1, Th-2 type cytokines in rheumatoid arthritis, osteoarthritis, asthma, atopic dermatitis and AIDS.
Clinical and experimental rheumatology 1997;15(3):315-23.
1997: Clerici M; Piconi S; Balotta C; Trabattoni D; Capetti A; Fusi M L; Ruzzante S; Longhi R; Colombo M C; Moroni M; Milazzo F
Pentoxifylline improves cell-mediated immunity and reduces human immunodeficiency virus (HIV) plasma viremia in asymptomatic HIV-seropositive persons.
The Journal of infectious diseases 1997;175(5):1210-5.
1997: Clerici M; Merola M; Ferrario E; Trabattoni D; Villa M L; Stefanon B; Venzon D J; Shearer G M; De Palo G; Clerici E
Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
Journal of the National Cancer Institute 1997;89(3):245-50.
1997: Clerici M; Clivio A; Shearer G M
Resistance to HIV infection: the genes are only part of the solution.
Trends in microbiology 1997;5(1):2-4.
1997: Vigano A; Balotta C; Trabattoni D; Bricalli D; Crupi L; Palomba E; Galli L; Salvaggio A; Fusi M L; Ruzzante S; Massironi E; Colombo M C; Principi N; Galli M; Clerici M
Long-term resistance to HIV infection in vertical HIV infection: cytokine production, HIV isolation, and HIV phenotype define long-term resistant hosts.
Pathobiology : journal of immunopathology, molecular and cellular biology 1997;65(4):169-76.
1997: Clerici M; Trabattoni D; Piconi S; Fusi M L; Ruzzante S; Clerici C; Villa M L
A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus.
Psychoneuroendocrinology 1997;22 Suppl 1():S27-31.
1996: Rizzardini G; Piconi S; Ruzzante S; Fusi M L; Lukwiya M; Declich S; Tamburini M; Villa M L; Fabiani M; Milazzo F; Clerici M
Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals.
AIDS (London, England) 1996;10(13):1535-42.
1996: Clerici M; Balotta C; Trabattoni D; Papagno L; Ruzzante S; Rusconi S; Fusi M L; Colombo M C; Galli M
Chemokine production in HIV-seropositive long-term asymptomatic individuals.
AIDS (London, England) 1996;10(12):1432-3.
1996: Lucey D R; Clerici M; Shearer G M
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.
Clinical microbiology reviews 1996;9(4):532-62.
1996: Marzi M; Vigano A; Trabattoni D; Villa M L; Salvaggio A; Clerici E; Clerici M
Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy.
Clinical and experimental immunology 1996;106(1):127-33.
1996: Viganò A; Balotta C; Trabattoni D; Salvaggio A; Riva C; Bricalli D; Crupi L; Colombo M C; Principi N; Galli M; Clerici M
Virologic and immunologic markers of disease progression in pediatric HIV infection.
AIDS research and human retroviruses 1996;12(13):1255-62.
1996: Clerici M; Balotta C; Meroni L; Ferrario E; Riva C; Trabattoni D; Ridolfo A; Villa M; Shearer G M; Moroni M; Galli M
Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection.
AIDS research and human retroviruses 1996;12(11):1053-61.
1996: Clerici M; Balotta C; Galli M
Soluble HIV suppressive factors: more than one Holy Grail?
Immunology today 1996;17(7):297-8.
1996: Clerici M; Balotta C; Salvaggio A; Riva C; Trabattoni D; Papagno L; Berlusconi A; Rusconi S; Villa M L; Moroni M; Galli M
Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection.
Blood 1996;88(2):574-9.
1996: Chougnet C; Wynn T A; Clerici M; Landay A L; Kessler H A; Rusnak J; Melcher G P; Sher A; Shearer G M
Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus.
The Journal of infectious diseases 1996;174(1):46-53.
1996: Clerici M; Shearer G M
Correlates of protection in HIV infection and the progression of HIV infection to AIDS.
Immunology letters 1996;51(1-2):69-73.
1996: Beretta A; Furci L; Burastero S; Cosma A; Dinelli M E; Lopalco L; DeSantis C; Tambussi G; Carrow E; Sabbatani S; Clerici M; Lazzarin A; Siccardi A G
HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection.
Immunology letters 1996;51(1-2):39-43.
1996: Clerici M; Sarin A; Berzofsky J A; Landay A L; Kessler H A; Hashemi F; Hendrix C W; Blatt S P; Rusnak J; Dolan M J; Coffman R L; Henkart P A; Shearer G M
Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin.
AIDS (London, England) 1996;10(6):603-11.
1996: Landay A L; Clerici M; Hashemi F; Kessler H; Berzofsky J A; Shearer G M
In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10.
The Journal of infectious diseases 1996;173(5):1085-91.
1996: Salvaggio A; Balotta C; Galli M; Clerici M
CD4 count in HIV infection is positively correlated to interferon-gamma and negatively correlated to interleukin-10 in vitro production.
AIDS (London, England) 1996;10(4):449-51.
1996: Meroni L; Trabattoni D; Balotta C; Riva C; Gori A; Moroni M; Luisa Villa M; Clerici M; Galli M
Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection.
AIDS (London, England) 1996;10(1):23-30.
1996: Shearer G M; Clerici M
Protective immunity against HIV infection: has nature done the experiment for us?
Immunology today 1996;17(1):21-4.
1995: Mozzanica N; Cattaneo A; Trabattoni D; Finzi A F; Schmitt E; Ferrario E; Clerici M; Vignati G; Villa M L
Production of type-1 and type-2 cytokines by peripheral blood mononuclear cells of psoriatic patients.
Immunology 1995;86(3):422-6.
1995: Chougnet C; Clerici M; Shearer G M
Role of IL12 in HIV disease/AIDS.
Research in immunology 1995;146(7-8):615-22.
1995: Pinto L A; Sullivan J; Berzofsky J A; Clerici M; Kessler H A; Landay A L; Shearer G M
ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids.
The Journal of clinical investigation 1995;96(2):867-76.
1995: Zehender G; Meroni L; Piconi S; De Maddalena C; Parravicini C; Clerici M; Ridolfo A L; Moroni M; Galli M
Frequent detection of antibodies against HTLV antigens in patients with AIDS-related non-Hodgkin lymphoma.
AIDS research and human retroviruses 1995;11(7):823-7.
1995: Blauvelt A; Clerici M; Lucey D R; Steinberg S M; Yarchoan R; Walker R; Shearer G M; Katz S I
Functional studies of epidermal Langerhans cells and blood monocytes in HIV-infected persons.
Journal of immunology (Baltimore, Md. : 1950) 1995;154(7):3506-15.
1995: Viganó A; Principi N; Villa M L; Riva C; Crupi L; Trabattoni D; Shearer G M; Clerici M
Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease progression.
The Journal of pediatrics 1995;126(3):368-74.
1995: Clerici M; Shearer G M
An Occam's razor approach to the immunopathogenesis of HIV infection.
AIDS (London, England) 1995;9 Suppl A():S33-40.
1995: Shearer G M; Clerici M; Sarin A; Berzofsky J A; Henkart P A
Cytokines in immune regulation/pathogenesis in HIV infection.
Ciba Foundation symposium 1995;195():142-7; discussion 147-53.
1994: Clerici M; Sarin A; Coffman R L; Wynn T A; Blatt S P; Hendrix C W; Wolf S F; Shearer G M; Henkart P A
Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(25):11811-5.
1994: Clerici M; Shearer G M
The Th1-Th2 hypothesis of HIV infection: new insights.
Immunology today 1994;15(12):575-81.
1994: Clerici M; Clark E A; Polacino P; Axberg I; Kuller L; Casey N I; Morton W R; Shearer G M; Benveniste R E
T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques.
AIDS (London, England) 1994;8(10):1391-5.
1994: Sarin A; Clerici M; Blatt S P; Hendrix C W; Shearer G M; Henkart P A
Inhibition of activation-induced programmed cell death and restoration of defective immune responses of HIV+ donors by cysteine protease inhibitors.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(2):862-72.
1994: Clerici M; Bevilacqua M; Vago T; Villa M L; Shearer G M; Norbiato G
An immunoendocrinological hypothesis of HIV infection.
Lancet 1994;343(8912):1552-3.
1994: Clerici M; Wynn T A; Berzofsky J A; Blatt S P; Hendrix C W; Sher A; Coffman R L; Shearer G M
Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus.
The Journal of clinical investigation 1994;93(2):768-75.
1994: Schulick R D; Muluk S C; Clerici M; Bermas B L; Via C S; Weir M R; Shearer G M
Value of in vitro CD4+ T helper cell function test for predicting long-term loss of human renal allografts.
Transplantation 1994;57(3):480-2.
1994: Clerici M; Levin J M; Kessler H A; Harris A; Berzofsky J A; Landay A L; Shearer G M
HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood.
JAMA : the journal of the American Medical Association 1994;271(1):42-6.
1994: Clerici M; Ferrario E; Trabattoni D; Viviani S; Bonfanti V; Venzon D J; Clerici E; Shearer G M; Villa M L
Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease.
European journal of cancer (Oxford, England : 1990) 1994;30A(10):1464-70.
1993: Clerici M; Lucey D R; Berzofsky J A; Pinto L A; Wynn T A; Blatt S P; Dolan M J; Hendrix C W; Wolf S F; Shearer G M
Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.
Science (New York, N.Y.) 1993;262(5140):1721-4.
1993: Clerici M; Sison A V; Berzofsky J A; Rakusan T A; Brandt C D; Ellaurie M; Villa M; Colie C; Venzon D J; Sever J L
Cellular immune factors associated with mother-to-infant transmission of HIV.
AIDS (London, England) 1993;7(11):1427-33.
1993: Clerici M; Yarchoan R; Blatt S; Hendrix C W; Ammann A J; Broder S; Shearer G M
Effect of a recombinant CD4-IgG on in vitro T helper cell function: data from a phase I/II study of patients with AIDS.
The Journal of infectious diseases 1993;168(4):1012-6.
1993: Via C S; Tsokos G C; Bermas B; Clerici M; Shearer G M
T cell-antigen-presenting cell interactions in human systemic lupus erythematosus. Evidence for heterogeneous expression of multiple defects.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(7):3914-22.
1993: Clerici M; Beltz J; Bertrando P; Fornara A; Garavaglia R; Iraci A; Merati O; Steiner V; Cazzullo C L
[Mental retardation and family environment: role of emotional factors]
Minerva psichiatrica 1993;34(3):163-72.
1993: Clerici M; DePalma L; Roilides E; Baker R; Shearer G M
Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages.
The Journal of clinical investigation 1993;91(6):2829-36.
1993: Clerici M; Hakim F T; Venzon D J; Blatt S; Hendrix C W; Wynn T A; Shearer G M
Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.
The Journal of clinical investigation 1993;91(3):759-65.
1993: Clerici M; Shearer G M
A TH1-->TH2 switch is a critical step in the etiology of HIV infection.
Immunology today 1993;14(3):107-11.
1993: Schulick R D; Clerici M; Dolan M J; Shearer G M
Limiting dilution analysis of interleukin-2-producing T cells responsive to recall and alloantigens in human immunodeficiency virus-infected and uninfected individuals.
European journal of immunology 1993;23(2):412-7.
1993: Shearer G M; Clerici M
Abnormalities of immune regulation in human immunodeficiency virus infection.
Pediatric research 1993;33(1 Suppl):S71-4; discussion S74-5.
1993: Clerici M
Cell-mediated immunity in HIV infection.
AIDS (London, England) 1993;7 Suppl 1():S135-40.
1992: Clerici M; Roilides E; Butler K M; DePalma L; Venzon D; Shearer G M; Pizzo P A
Changes in T-helper cell function in human immunodeficiency virus-infected children during didanosine therapy as a measure of antiretroviral activity.
Blood 1992;80(9):2196-202.
1992: Clerici M; Landay A L; Kessler H A; Phair J P; Venzon D J; Hendrix C W; Lucey D R; Shearer G M
Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 1992;166(4):723-30.
1992: Clerici M; Roilides E; Via C S; Pizzo P A; Shearer G M
A factor from CD8 cells of human immunodeficiency virus-infected patients suppresses HLA self-restricted T helper cell responses.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(18):8424-8.
1992: Shearer G M; Clerici M
How human immunodeficiency virus ravages the immune system.
Current opinion in immunology 1992;4(4):463-5.
1992: Bertrando P; Beltz J; Bressi C; Clerici M; Farma T; Invernizzi G; Cazzullo C L
Expressed emotion and schizophrenia in Italy. A study of an urban population.
The British journal of psychiatry : the journal of mental science 1992;161():223-9.
1992: Clerici M; Giorgi J V; Chou C C; Gudeman V K; Zack J A; Gupta P; Ho H N; Nishanian P G; Berzofsky J A; Shearer G M
Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1.
The Journal of infectious diseases 1992;165(6):1012-9.
1992: Blay R; Hernandez D; Betts M; Clerici M; Lucey D R; Hendrix C; Hoffman T; Golding B
Brucella abortus stimulates human T cells from uninfected and HIV-infected individuals to secrete IFN gamma: implications for use of Brucella abortus as a carrier in development of human vaccines.
AIDS research and human retroviruses 1992;8(4):479-86.
1992: Clerici M; Albonetti S; Papa R; Penati G; Invernizzi G
Alexithymia and obesity. Study of the impaired symbolic function by the Rorschach test.
Psychotherapy and psychosomatics 1992;57(3):88-93.
1992: Shearer G M; Clerici M
T helper cell immune dysfunction in asymptomatic, HIV-1-seropositive individuals: the role of TH1-TH2 cross-regulation.
Chemical immunology 1992;54():21-43.
1991: De Groot A S; Clerici M; Hosmalin A; Hughes S H; Barnd D; Hendrix C W; Houghten R; Shearer G M; Berzofsky J A
Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: correlation with a cytotoxic T cell epitope.
The Journal of infectious diseases 1991;164(6):1058-65.
1991: Lucey D R; Melcher G P; Hendrix C W; Zajac R A; Goetz D W; Butzin C A; Clerici M; Warner R D; Abbadessa S; Hall K
Human immunodeficiency virus infection in the US Air Force: seroconversions, clinical staging, and assessment of a T helper cell functional assay to predict change in CD4+ T cell counts.
The Journal of infectious diseases 1991;164(4):631-7.
1991: Berzofsky J A; Pendleton C D; Clerici M; Ahlers J; Lucey D R; Putney S D; Shearer G M
Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.
The Journal of clinical investigation 1991;88(3):876-84.
1991: Muluk S C; Clerici M; Via C S; Weir M R; Kimmel P L; Shearer G M
Correlation of in vitro CD4+ T helper cell function with clinical graft status in immunosuppressed kidney transplant recipients.
Transplantation 1991;52(2):284-91.
1991: Clerici M; Berzofsky J A; Shearer G M; Tacket C O
Exposure to human immunodeficiency virus (HIV) type I indicated by HIV-specific T helper cell responses before detection of infection by polymerase chain reaction and serum antibodies [corrected]
The Journal of infectious diseases 1991;164(1):178-82.
1991: Clerici M; Tacket C O; Via C S; Lucey D R; Muluk S C; Zajac R A; Boswell R N; Berzofsky J A; Shearer G M
Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection.
European journal of immunology 1991;21(6):1345-9.
1991: Roilides E; Clerici M; DePalma L; Rubin M; Pizzo P A; Shearer G M
Helper T-cell responses in children infected with human immunodeficiency virus type 1.
The Journal of pediatrics 1991;118(5):724-30.
1991: Lucey D R; McGuire S A; Clerici M; Hall K; Benton J; Butzin C A; Ward W W; Shearer G; Boswell R N; Hendrix C W
Comparison of spinal fluid beta 2-microglobulin levels with CD4+ T cell count, in vitro T helper cell function, and spinal fluid IgG parameters in 163 neurologically normal adults infected with the human immunodeficiency virus type 1.
The Journal of infectious diseases 1991;163(5):971-5.
1991: Clerici M; Lucey D R; Zajac R A; Boswell R N; Gebel H M; Takahashi H; Berzofsky J A; Shearer G M
Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(7):2214-9.
1991: Clerici M; Landay A L; Kessler H A; Zajac R A; Boswell R N; Muluk S C; Shearer G M
Multiple patterns of alloantigen presenting/stimulating cell dysfunction in patients with AIDS.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(7):2207-13.
1991: Clerici M; Via C S; Lucey D R; Roilides E; Pizzo P A; Shearer G M
Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infection.
European journal of immunology 1991;21(3):665-70.
1991: Muluk S C; Clerici M; Via C S; Wier M R; Kimmel P L; Shearer G M
A new approach for analysis of the mixed lymphocyte reaction that is predictive for human renal allograft rejection.
Transplantation proceedings 1991;23(1 Pt 2):1274-6.
1991: Fuchs D; Shearer G M; Boswell R N; Lucey D R; Clerici M; Reibnegger G; Werner E R; Zajac R A; Wachter H
Negative correlation between blood cell counts and serum neopterin concentration in patients with HIV-1 infection.
AIDS (London, England) 1991;5(2):209-12.
1991: Invernizzi G; Bressi C; Bertrando P; Passerini A; Giannelli A; Clerici M; Biglioli P; Cazzullo C L
Emotional profiles of families with a heart-operated patient: a pilot study.
Psychotherapy and psychosomatics 1991;55(1):1-8.
1991: Berzofsky J A; Pendleton C D; Clerici M; Ahlers J; Lucey D R; Putney S D; Shearer G M
Peptides containing multideterminant clusters of human immunodeficiency virus envelope induce murine and human T-cell responses in diverse histocompatibility types.
Transactions of the Association of American Physicians 1991;104():69-77.
1991: Villa M L; Armelloni S; Ferrario E; Ottaviani F; Clerici M
Interference of cephalosporins with immune response: effects of cefonicid on human T-helper cells.
International journal of immunopharmacology 1991;13(8):1099-107.
1991: Blackburn R; Clerici M; Mann D; Lucey D R; Goedert J; Golding B; Shearer G M; Golding H
Common sequence in HIV 1 GP41 and HLA class II beta chains can generate crossreactive autoantibodies with immunosuppressive potential early in the course of HIV 1 infection.
Advances in experimental medicine and biology 1991;303():63-9.
1990: Papa R; Clerici M; Invernizzi G; Penati G
[Severe surgical obesity. A psychiatric evaluation]
Annali italiani di chirurgia 1990;61(4):375-88.
1990: Clerici M; Papa R; Basile R; Invernizzi G
[The experience of the corporal self and the Rorschach test in severe obesity under medical-surgical treatment]
Annales médico-psychologiques 1990;148(5):483-94.
1990: Clerici M; Stocks N I; Zajac R A; Boswell R N; Via C S; Shearer G M
Circumvention of defective CD4 T helper cell function in HIV-infected individuals by stimulation with HLA alloantigens.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(9):3266-71.
1990: Invernizzi G; Clerici M; Bertrando P; Bressi C; Cazzullo C L
[Family expressed emotion. From research to therapeutic intervention]
Minerva psichiatrica 1990;31(2):89-96.
1990: Fuchs D; Shearer G M; Boswell R N; Clerici M; Reibnegger G; Werner E R; Zajac R A; Wachter H
Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production.
Clinical and experimental immunology 1990;80(1):44-8.
1990: Via C S; Tsokos G C; Stocks N I; Clerici M; Shearer G M
Human in vitro allogeneic responses. Demonstration of three pathways of T helper cell activation.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(7):2524-8.
1990: Clerici M; Shearer G M
Differential sensitivity of human T helper cell pathways by in vitro exposure to cyclosporin A.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(7):2480-5.
1990: Hosmalin A; Clerici M; Houghten R; Pendleton C D; Flexner C; Lucey D R; Moss B; Germain R N; Shearer G M; Berzofsky J A
An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(6):2344-8.
1990: Clerici M; Stocks N I; Zajac R A; Boswell R N; Shearer G M
Accessory cell function in asymptomatic human immunodeficiency virus-infected patients.
Clinical immunology and immunopathology 1990;54(2):168-73.
1989: Clerici M; Stocks N I; Zajac R A; Boswell R N; Lucey D R; Via C S; Shearer G M
Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.
The Journal of clinical investigation 1989;84(6):1892-9.
1989: Clerici M; Stocks N I; Zajac R A; Boswell R N; Bernstein D C; Mann D L; Shearer G M; Berzofsky J A
Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals.
Nature 1989;339(6223):383-5.
1989: Golding H; Shearer G M; Hillman K; Lucas P; Manischewitz J; Zajac R A; Clerici M; Gress R E; Boswell R N; Golding B
Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals.
The Journal of clinical investigation 1989;83(4):1430-5.
1989: Clerici M; Beltz J; Bressi C; Bertrando P; Invernizzi G; Cazzullo C L
[Emotional expression: from research to psychosocial treatment]
Acta psychiatrica Belgica 1989;89(1-2):31-9.
1989: Bertrando P; Bressi C; Clerici M; Cunteri L; Cazzullo C L
Family assessment and linguistic interaction: analysis of the Camberwell Family Interview.
Psychotherapy and psychosomatics 1989;51(3):120-7.
1988: Clerici M; Garini R; Capitanio C; Zardi L; Carta I; Gori E
Involvement of families in group therapy of heroin addicts.
Drug and alcohol dependence 1988;21(3):213-6.
1988: Clerici M; Villa M L; Clerici E
[Graft versus host reaction and hybrid resistance in experimental models and clinical practice]
Bollettino dell'Istituto sieroterapico milanese 1988;67(3):177-96.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Mario Clerici

Research Profile (preview)

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Phenomena

Physiology

Procedures

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Mario Clerici (preview)

All Publications